-
Vortrag
Efficacy of Fremanezumab in Migraine Patients With Pain or Psychiatric Comorbidities and Documented Inadequate Response to 2-4 Prior Migraine Preventive Medication Classes
Speaker
Datum:
21.10.2022 ,
Zeit:
12:00
|
Thema: 18. Sonstiges
Details
-
Vortrag
Real-World Effectiveness of Fremanezumab in Patients with Refractory Migraine from a US Tertiary Headache Center who Switched from Erenumab
Speaker
Datum:
21.10.2022 ,
Zeit:
12:00
|
Thema: 18. Sonstiges
Details
-
Vortrag
Consecutive Migraine-free Days with Fremanezumab Treatment: Results of the Double-blind, Placebo-controlled FOCUS Study
Speaker
Datum:
21.10.2022 ,
Zeit:
12:00
|
Thema: 18. Sonstiges
Details